Evogene (EVGN) Posts Q2 Loss of 22c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P 500, Dow rise on Mideast deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil nears two-month lows on reports of imminent US-Iran peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Evogene to Present at Credit Suisse 2014 Basic Materials Conference
August 19, 2014 7:00 AM EDTREHOVOT, Israel, Aug. 19, 2014 (GLOBE NEWSWIRE) -- Evogene Ltd. (NYSE: EVGN) (TASE: EVGN), a leading plant genomics company specializing in enhancing crop productivity for the food, feed and biofuel industries, announced today that Mr. Ofer Haviv, Evogene's President and CEO, will present at the Credit Suisse 2014 Basic Materials Conference taking place at the Credit Suisse Auditorium, located at One Madison Avenue in New York City, September 16-18, 2014. The presentation will take place on Thursday, September 18, at 11:45 am.
... More
